Provident Investment Management, Inc. VRTX VERTEX PHARMACEUTICALS INC

Ownership history in Provident Investment Management, Inc.  ·  20 quarters on record

AI Ownership Summary

Provident Investment Management, Inc. reported VERTEX PHARMACEUTICALS INC (VRTX) in 20 quarterly 13F filings from 2024 Q1 through 2026 Q1. Peak portfolio weight reached 7.14% in 2025 Q1. The latest visible filing shows VRTX at 6.55% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this VRTX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Provident Investment Management, Inc.'s position in VERTEX PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

VRTX was reported at 6.55% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
7.14% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Provident Investment Management, Inc. held VRTX — position size vs. price
% of Fund (quarterly)    VRTX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 147,620 -1,638 -1.1% 6.55% $65.9M 2026-05-13 $453.06
2025 Q4 REDUCED 149,258 -4,148 -2.7% 6.16% $67.7M 2026-02-04 $470.52
2025 Q3 REDUCED 153,406 -5,301 -3.3% 5.30% $60.1M 2025-11-19 $421.03
2025 Q2 ADDED 158,707 +2,382 +1.5% 6.04% $70.7M 2025-08-26 $387.18
2025 Q1 ADDED 156,325 +1,259 +0.8% 7.14% $75.8M 2025-05-09 $424.99
2024 Q4 REDUCED 155,066 -439 -0.3% 5.96% $62.4M 2025-02-12 $453.20
2024 Q3 REDUCED 155,505 -4,357 -2.7% 6.45% $72.3M 2024-11-12 $490.00
2024 Q2 REDUCED 159,862 -263 -0.2% 6.82% $74.9M 2024-08-07 $465.89
2024 Q1 REDUCED 160,125 -194 -0.1% 5.90% $66.9M 2024-05-14 $428.59
11 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Provident Investment Management, Inc. and VRTX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Provident Investment Management, Inc. reported owning VRTX?

Provident Investment Management, Inc. reported VRTX across 9 quarterly 13F filings, from 2024 Q1 through 2026 Q1.

What was the largest reported VRTX position in Provident Investment Management, Inc.'s portfolio?

The largest reported portfolio weight for VRTX was 7.14% in 2025 Q1.

What is the latest reported VRTX position on this page?

The most recent filing on this page is 2026 Q1, when Provident Investment Management, Inc. reported 147,620 shares, equal to 6.55% of portfolio, with an estimated market value of $65.9M.

What does the chart on this VRTX ownership page compare?

The chart compares Provident Investment Management, Inc.'s quarterly VRTX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Provident Investment Management, Inc. time their VRTX position?

Based on 13F filing dates vs. subsequent VRTX price moves, Provident Investment Management, Inc. correctly timed 8 out of 19 reported position changes (42%). The annualised alpha on VRTX relative to SPY over the holding period was +5.0%.

← Back to Provident Investment Management, Inc. Holdings